Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 8/1/1998


1.		Phase II Study of Desferrioxamine for Children with Refractory Lymphoblastic Leukemia and non-Hodgkin's Lymphoma (Summary Last Modified 08/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				21 and under at diagnosis				NCI				POG-9461

Last Modified: 10/1/1999


2.		Phase II Randomized Study of Topotecan with vs without Cyclophosphamide and with vs without an Investigational Window Study of Deferoxamine for Refractory Neuroblastoma (Summary Last Modified 10/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				21 or under at diagnosis				NCI				POG-P9462 CCG-P9462, POG-9462

Last Modified: 9/1/1993


3.		Phase I Trial of Desferrioxamine in Children with Recurrent or Refractory Neuroblastoma (Summary Last Modified 09/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				21 and under				NCI				POG-9248

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute